Lv1
50 积分 2024-10-15 加入
Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticity
3天前
已完结
The tumor microenvironment’s role in the response to immune checkpoint blockade
16天前
已完结
The adenosine pathway in immuno-oncology
16天前
已完结
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
25天前
已完结
PROTAC targeted protein degraders: the past is prologue
1个月前
已完结
Inhalable Lipid Nanoparticles for Macrophage-Specific STING Gene Editing to Ameliorate Pulmonary Fibrosis
2个月前
已完结
The next generation of immunotherapies for lung cancers
2个月前
已完结
Liposomal delivery of CRISPR/Cas9
2个月前
已完结
Active biointegrated living electronics for managing inflammation
4个月前
已完结
Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression
4个月前
已完结
皖公网安备34019202002308
